Isotopes — An Eight-Year Summary of U. S. Distribution and Utilization, USAEC, Superintendent of Documents, Washington, D. C., March, 1955.
9.
StoreyR. H.: Personal communication.
10.
CunninghamR. E.: U. S. Atomic Energy Commission Licensing and Regulation of Radiopharmaceuticals, in AndrewsG. A., KniseleyR. M., and WagnerH. N.Jr. (Eds.): Radioactive Pharmaceuticals, U. S. Atomic Energy Commission, Washington, D. C., April, 1966. p. 679.
11.
NumerofP.: Personal communication.
12.
The Pharmacopeia of the United States of America, Fourteenth Revision, New York. U. S. Pharmacopeial Convention, Inc., 1950.
13.
The National Formulary, Ninth Edition, Washington, American Pharmaceutical Association, 1950.
14.
TabernD. L.: Radioactively Tagged Compounds Available from Abbott Laboratories, December 1, 1950.
15.
The Pharmacopeia of the United States of America, Seventeenth Revision, New York, U. S. Pharmacopeial Convention, Inc., 1965.
16.
The National Formulary, Twelfth Edition, Washington, American Pharmaceutical Association, 1965.
17.
VacikJ. P.: Faculty Forum in Radiopharmacy. Am. J. Pharm. Ed.27: 136–140 (Winter) 1963.
18.
RubinI.: Who Will Dispense Radioactive Drugs?Am. Profess. Pharmacist30: 28–29 (May) 1964.
19.
CharltonJ. C.: Problems of Radioactive Pharmaceuticals, in AndrewsG. A., KniseleyR. M., and WagnerH. N.Jr. (Eds.), Radioactive Pharmaceuticals, pp. 45–46, U. S. Atomic Energy Commission CONF-651111, Washington, 1966.
20.
GleasonG. I.: Panel Discussion, in AndrewsG. A., KniseleyR. M., and WagnerH. N.Jr. (Eds.), ibid. p. 215.
21.
NumerofP.: Panel Discussion, in AndrewsG. A., KniseleyR. M., and WagnerH. N.Jr. (Eds.), ibid. p. 215.